2m 2m 2m 2m 2m 2m 2m
CAPRICOR THERAP (CAPR)
NASDAQ
$29.51-$0.09 (-0.30%)
Price as of Jun 23, 2026 7:36 PM EDT- $1.7BMarket Cap
- 220.00%1-Year Change
- BiotechnologyIndustry
CAPRICOR THERAP (CAPR)
$29.51-$0.09 (-0.30%)
CAPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.60 | ||
Change | +$0.26 (+0.89%) | ||
Open | $28.73 | ||
High | $29.99 | ||
Low | $28.53 | ||
Previous Close | $29.34 | ||
Volume | 794,705 | ||
30-Day Average Volume | 989,181 | ||
1-Week Change | 13.63% | ||
1-Month Change | 2.53% | ||
1-Year Change | 220.00% | ||
3-Year Change | 486.14% | ||
5-Year Change | 467.05% | ||
Fundamentals | |||
Shares Outstanding | 57.9M | ||
Total Assets | $326.3M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$33.9M | ||
Free Cash Flow | -$34.4M | ||
EBIT | -$33.9M | ||
EBITDA | -$33.4M | ||
Net Working Capital | $249.5M | ||
EPS | -$0.59 | ||
Enterprise Value/EBITDA | -48 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -50 | ||
PEG | -11 | ||
Price/Free Cash Flow | -49 | ||
Price/Operating Cash Flow | -58 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/05/2019 | ||
Earnings & Revenue